Skip to content
Author
PUBLISHED: | UPDATED:
Getting your Trinity Audio player ready...

* Internet drug pioneer faces up to 20 years in prison

* U.S. seeks forfeiture of $95 million in proceeds

* Alleged conspiracy dates back to 2005-2006

MIAMI, June 15 (Reuters) – A pioneer of Canada’s online

pharmaceutical trade is under arrest in Florida on charges of

selling prescription drugs in the United States without ensuring

their safety or authenticity.

Andrew Strempler, 39, faces up to 20 years in federal prison

if convicted on the charges.

The government also seeks to recover at least $95 million in

proceeds from his alleged conspiracy to sell unlicensed or

illegal drugs to U.S. customers, according to a grand jury

indictment.

At least some of the drugs, in packages shipped to U.S.

clients between January 2005 and June 2006, were either

counterfeit or misbranded, according to the year-old indictment.

The case against Strempler was made public as he made his

initial appearance in federal court in Miami on Thursday. He was

arrested on Wednesday on charges of conspiracy to commit wire

and mail fraud.

An attorney for Strempler was not immediately available for

comment. He is due to be arraigned next Wednesday.

Strempler is a former head of RxNorth.com, the Internet,

mail and telephone order pharmacy whose operations were the

focus of the indictment.

As part of his online pharmacy scheme, Strempler set up a

facility in the Bahamas to fill orders made through RxNorth with

labels stating that they had been filled by RxNorth in Canada,

the indictment said.

“Strempler and others caused the individual customer

packages to be shipped in bulk from the Bahamas to the United

Kingdom and the Netherlands Antilles, from where the individual

customer packages were mailed to customers in the United

States,” it said.

“It was the purpose of the scheme and artifice of the

defendant to unlawfully enrich himself by selling prescription

drugs to individuals in the United States, falsely representing

that RxNorth was selling safe prescription drugs in compliance

with the rules of regulatory authorities in Canada, the United

Kingdom and/or the United States,” the indictment said.

RxNorth shut down in January 2008 after Strempler sold it to

a competitor.

(Reporting By Tom Brown; Editing by Xavier Briand)